Semaglutide May Reduce Psychiatric Hospitalizations | Science News

New research reveals semaglutide, the drug behind Ozempic and Wegovy, may significantly reduce psychiatric hospitalizations in people with bipolar disorder—by 21%—hinting at powerful brain-protective effects beyond weight or diabetes management. While other GLP-1 drugs didn’t show the same benefit, this points to semaglutide’s unique potential in mental health, sparking fresh hope for treating mood disorders through existing medications. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ac386cac7c1befc0